- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05345951
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
A Randomized Clinical Trial: Examining a Brief Parent-intervention to Reduce College Student Drinking and Cannabis Use
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
College is a high-risk window for alcohol and cannabis use, with almost 80% of college students reporting consuming alcohol in the past year and more than 1 in 3 reporting heavy episodic drinking in the past month. A recent National College Health survey indicated that about 30% of students reported using cannabis weekly or more often. This is concerning considering present-day cannabis has an increased potency with tetrahydrocannabinol (THC) levels in cannabis in the US increasing over 200% since 1990. Additionally, availability has increased due to increased legalization in the US. Cannabis use is associated with a number of negative outcomes such as impaired memory and concentration, reduced impulse control, poor class attendance and lower academic performance, increased anxiety/depression, and increased impaired driving. Additionally, a number of studies have shown an increase in co-use of alcohol and cannabis (use of both substances in the same day) or simultaneously so their effects overlap, and studies show that these combined behaviors results in much greater harm than alcohol-only use. The proposed research will attempt to curb the alarming trends associated with alcohol and cannabis use by conducting a randomized controlled trial testing a modified version of the Turrisi and associates efficacious brief Parent-Based Intervention (e-PBI) that includes additional data-driven content for parents to have broader discussions about cannabis use (e-PBI+).
The design is a 3-arm (e-PBI+, e-PBI, Attention-Matched control) randomized controlled trial with 5 waves of data collection. The study will enroll an ethnically diverse sample of 900 parent-student dyads (N at final follow-up). Students will complete assessments of all the primary, secondary, and tertiary outcomes at five times: pre-intervention baseline, and 3-month, 6-month, 9-month, and 12-month follow-ups as well as provide urine samples at 3-month and 9-month to corroborate cannabis use reported on the timeline followback. Parents will complete a baseline and 3-month follow-up survey.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Robert Turrisi, PhD
- Phone Number: 814-865-7808
- Email: rjt13@psu.edu
Study Contact Backup
- Name: Sarah Ackerman, MS
- Phone Number: 814-865-4222
- Email: sdf5013@psu.edu
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Recruiting
- Penn State University
-
Contact:
- Robert Turrisi, PhD
- Phone Number: 814-865-7808
- Email: rjt13@psu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Parent and teen both consent and complete baseline (forming a dyad testing unit)
Exclusion Criteria:
- Outside of the teen age range; both parent and teen do not consent and complete baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: e-PBI+
The e-PBI+ is an electronic handbook developed by the PI to guide parents in discussing drinking, behaviors, and consequences with their teens, with additional content on cannabis use.
|
The e-PBI+ is a preventive parent-based intervention emphasizing parent-teen communication on drinking/risks of alcohol abuse, with the addition of data-driven cannabis content to guide parent communications with their students (e.g., cannabis content focusing on the endocannabinoid system; acute and chronic cannabis use effects on the brain, cognition, and development; THC potency in present-day cannabis; cannabis use effects on mental and physical health, including psychosis, depression, and anxiety; respiratory/cardiovascular/sleep problems; cannabidiol (CBD) content, myths; and cannabis effects on psychosocial function).
Together the goals are to reduce alcohol and cannabis use in college students.
|
Experimental: e-PBI
the e-PBI is an electronic handbook developed by the PI to guide parents in discussing drinking, behaviors, and consequences with their teens.
|
The e-PBI is currently a model prevention resource at NIAAA's College Alcohol Intervention Matrix and the research was discussed in the most recent Surgeon General's Report as one of two prevention approaches that met the rigorous criteria to be considered "efficacious".
The first section of the e-PBI provides an introduction to the problem of substance use.
The second section focuses on specific skill building strategies that parents can use to improve communication channels with their teen.
Third is a section that addresses peer influence and provides strategies for developing assertiveness.
The fourth section is an in-depth discussion of underage drinking, physiological and psychological effects, mixing alcohol with other drugs, motives for why students drink and don't drink, warning signs, risky binge-type drinking, impaired driving, riding with impaired drivers, alcohol and sexual assault, and how to communicate about parents' experiences when they were young.
|
No Intervention: e-AC
The e-AC is the attention matched control.
They will receive general university-related materials to read, sections on parent and family resources (e.g., message from administrators, getting involved, academic calendar), advising, money matters, financial aid, campus life (arts, entertainment, housing, etc.), health and safety (health, counseling services, alcohol and drug laws).
It is equivalent to the e-PBI+ and e-PBI on length of content and time to read.
This group will not receive an intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Examine Changes in Alcohol Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
A standard drink definition will be provided, indicating that a standard drink consists of 12 oz. of beer or wine cooler, 8.5 oz. of malt liquor, 4 oz. of wine, or 1.5 oz. of hard liquor.
Using the Timeline Followback (TLFB; Sobell & Sobell, 1996), participants will indicate how many drinks they consumed on each day of the past three months.
For days alcohol was consumed, participants will also note the number of hours spent drinking.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Self-reported measures of retrospective cannabis use will be collected via the TLFB calendar with modifications that incorporate current methods of consumption (e.g., joint, blunt, pipe/bowl, bong, edible, vaporizer cartridges, concentrate [including wax, oil, rosin, capsules, and tinctures], and other) and amount (e.g., in grams/mg).
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Examine Changes in Consequences of Alcohol Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Alcohol-related consequences (e.g., said or done embarrassing things, blackout) from the past three months will be measured using the established Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ; Read, Kahler, Strong, & Colder, 2006).
Response options will be measured on a 7-point scale ranging from (0) no, not in the past 3 months to (6) 11 or more times in the past 3 months.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Consequences of Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Participants will be asked to report on the frequency of experiencing a variety of cannabis-related consequences (e.g., neglected obligations, driven a car high) within the past three months using the Marijuana Consequences Questionnaire (MACQ; Simons, Dvorak, Merrill, & Read, 2012).
Response options will be measured on a 7-point scale ranging from (0) no, not in the past 3 months to (6) 11 or more times in the past 3 months
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Co-Use of Alcohol and Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Days on the TLFB when participants report using both alcohol and cannabis will be identified as co-use days.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Examine Changes in Parental Communication
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Parental communication about alcohol, cannabis, and consequences of using alcohol and cannabis will be assessed separately for mothers and fathers.
Participants will be asked how often their parent discussed these topics with them within the past three months.
Response options will be measured on a 5-point scale ranging from (0) not at all to (4) a great deal.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in General Parental Practices
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
General communication (e.g., my mother/father is there for me when I want to talk) will be assessed separately for mothers and fathers based on level of agreement on a 7-point scale ranging from (1) strongly disagree to (7) strongly agree.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Alcohol Use Motives
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Motives will be assessed for using alcohol (e.g., to be sociable; Cooper, 1994).
Response options range from (1) almost never/never to (5) almost always/always.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Cannabis Use Motives
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Motives will be assessed for using cannabis (e.g., to relieve boredom; Lee et al., 2009).
Response options range from (1) Almost never/never to (5) Almost always/always.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Alcohol Use Expectancies
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Expectancies for using alcohol (e.g., I will feel badly about myself because of my drinking) will be measured.
Response options range from (1) strongly disagree to (7) strongly agree.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Cannabis Use Expectancies
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Expectancies for using cannabis (e.g., I won't be as sharp mentally because of my cannabis use) will be measured.
Response options range from (1) strongly disagree to (7) strongly agree.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Alcohol Use Willingness
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Willingness to use alcohol will be measured to assess participants' willingness to: 1) drink once or twice in two hours; 2) drink 3-4 times in two hours; and 3) drink 5+ times in two hours.
Response options will be on a 7-point scale ranging from (1) strongly disagree to (7) strongly agree.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Cannabis Use Willingness
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Willingness to use cannabis will be assessed with four items: occasionally, regularly, weekly, and daily.
Response options range from (1) strongly disagree to (7) strongly agree.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Peer Descriptive Norms of Alcohol Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Perceived peer descriptive norms of drinking for the past three months will be measured using the Daily Drinking Questionnaire (DDQ; Collins, Parks, & Marlatt, 1985).
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Peer Descriptive Norms of Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
Perceived peer descriptive norms of cannabis use for the past three months will be captured by asking how often their closest friends used cannabis in the past 3 months, (0) never to (6) 40 or more times.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Peer Injunctive Norms of Alcohol Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess peer injunctive norms of alcohol use, participants will be asked to indicate how acceptable their closest friends would find a list of situations (e.g., drinking enough alcohol to pass out) using a (1) strongly disapprove to (7) strongly approve scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Peer Injunctive Norms of Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess peer injunctive norms of cannabis use, participants will be asked to indicate how acceptable their closest friends would find a list of situations (e.g., using cannabis occasionally) using a (1) strongly disapprove to (7) strongly approve scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Parental Injunctive Norms of Alcohol Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess parental injunctive norms of alcohol use, participants will be asked to indicate how acceptable their parents would find a list of situations (e.g., drinking alone) using a (1) strongly disapprove to (7) strongly approve scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Parental Injunctive Norms of Cannabis Use
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess parental injunctive norms of cannabis use, participants will be asked to indicate how acceptable their parents would find a list of situations (e.g., using cannabis occasionally) using a (1) strongly disapprove to (7) strongly approve scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Self Regulation
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess self-regulation, participants will be asked to indicate how much a list of statement apply to them (e.g., When I'm bored I fidget or can't sit still; I can calm myself down when I'm excited or all wound up) using a (1) not at all true for me to (5) really true for me scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Examine Changes in Goal Setting
Time Frame: Baseline, 3 month, 6 month, 9 month, 12 month
|
To assess goal setting, participants will be asked to indicate to what extent the goal is important to them (e.g., To be around friends; To be admired by many) using a (1) not at all true for me to (5) really true for me scale.
|
Baseline, 3 month, 6 month, 9 month, 12 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robert Turrisi, PhD, Penn State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 226723
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use
-
Centre hospitalier de l'Université de Montréal...RecruitingCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Oregon Research InstituteCompletedCannabis Use Disorder, Mild | Cannabis Use Disorder, ModerateUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)Not yet recruitingTobacco Use | Cannabis | Cannabis Use | Vaping | THC | Cannabis SmokingUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
Hartford HospitalYale UniversityNot yet recruitingMarijuana Use | Cannabis Use | Cannabis Intoxication
-
McMaster UniversityCenter for Medicinal Cannabis ResearchNot yet recruitingCannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe
Clinical Trials on e-PBI+
-
Pyramid BiosciencesCompletedFormulation Bridging and Food Effect in Healthy VolunteersUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Not yet recruiting
-
Liminal BioSciences Ltd.TerminatedAlström SyndromeUnited Kingdom
-
Liminal BioSciences Ltd.CompletedDiabetes | Inflammation and FibrosisUnited Kingdom
-
Phoenix Biotechnology, IncUnknownPancreatic CancerUnited States
-
Pyramid BiosciencesTerminatedSolid Tumor, Adult | Desmoplastic Small Round Cell Tumor | Brain Tumor, PrimaryFrance, United States, Spain, Hong Kong, United Kingdom, Australia, Singapore, Germany, Korea, Republic of, Italy, Denmark
-
Pyramid BiosciencesCompletedAbsorption, Metabolism and Excretion in Healthy VolunteersUnited States
-
Liminal BioSciences Ltd.Syneos HealthTerminated
-
Pyramid BiosciencesCompletedFood Effect in Healthy VolunteersUnited States